INCOME TAX (Tables)

12 Months Ended

Mar. 31, 2025

Income Tax Disclosure [Abstract]

Schedule of Total Income Tax Expense (Benefit)

Total income tax expense (benefit) was allocated as follows (dollars in thousands):

	For the twelve months ended March 31,
	2025		2024		2023
Continuing operations	$	25,342	$	24,270	$	5,252
Discontinued operations	(2,131)		(2,332)		(7,070)
	$	23,211	$	21,938	$	(1,818)

Schedule of Components of Income Tax Expense (Benefit)

Income tax expense (benefit) attributable to continuing operations consists of (dollars in thousands): 

	For the twelve months ended March 31,
	2025		2024		2023
Current:
U.S. Federal	$	20,300	$	21,014	$	6,325
Non-U.S.	480		662		1086
State	4,869		3,384		(2,274)
	25,649		25,060		5,137
Deferred:
U.S. Federal	23		(101)		155
Non-U.S.	(300)		(387)		(83)
State	(30)		(302)		43
	(307)		(790)		115
Total	$	25,342	$	24,270	$	5,252

Schedule of Income before Income Tax, Domestic and Foreign

Income (loss) before income tax attributable to U.S. and non-U.S. continuing operations consists of (dollars in thousands):

	For the twelve months ended March 31,
	2025		2024		2023
U.S.	$	18,431	$	33,892	$	(122,994)
Non-U.S.	4,409		469		4,140
Total	$	22,840	$	34,361	$	(118,854)

Schedule of Effective Income Tax Rate Reconciliation

Below is a reconciliation of expected income tax expense (benefit), computed by applying the U.S. federal statutory rate of 21.0% to income (loss) before income taxes, to actual income tax expense from continuing operations (dollars in thousands): 

	For the twelve months ended March 31,
	2025		2024		2023
Computed expected income tax expense (benefit)	$	4,797	$	7,216	$	(24,959)
Increase (reduction) in income taxes resulting from:
State income taxes, net of federal benefit	4,407		2,494		(2,440)
Research and other tax credits	(3,621)		(3,012)		(4,363)
Nondeductible expenses	1,114		2,169		669
Stock-based compensation	4,056		2,013		3,486
Non-U.S. subsidiaries taxed at other rates	(757)		(1,036)		491
Adjustment to valuation allowances	12,460		14,209		33,197
Other, net	2,886		217		(829)
	$	25,342	$	24,270	$	5,252

Schedule of Deferred Tax Assets and Liabilities

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities at March 31, 2025 and 2024 are presented below (dollars in thousands).  

	March 31,
	2025		2024
Deferred tax assets:
Accrued expenses	$	5,072	$	5,849
Lease liabilities	8,453		10,107
Net operating loss carryforwards	35,268		30,408
Stock-based compensation	8,734		7,346
Nonqualified deferred compensation	2,788		2,809
Tax credit carryforwards	10,641		9,764
Capitalized research and development	58,556		45,499
Other	2,236		1,477
Total deferred tax assets	131,748		113,259
Less valuation allowance	(105,040)		(81,284)
Net deferred tax assets	26,708		31,975
Deferred tax liabilities:
Prepaid expenses	(3,546)		(2,821)
Property and equipment	(1,412)		(1,976)
Right-of-use assets	(4,657)		(6,186)
Intangible assets	(4,019)		(7,118)
Deferred commissions	(11,153)		(12,098)
Other	(181)		(364)
Total deferred tax liabilities	(24,968)		(30,563)
Net deferred tax assets	$	1,740	$	1,412

Schedule of Unrecognized Tax Benefits Roll Forward

The following table sets forth changes in the total gross unrecognized tax benefits for the twelve months ended March 31, 2025, 2024 and 2023 (dollars in thousands):

	For the twelve months ended March 31,
	2025		2024		2023
Balance at beginning of period	$	22,922	$	21,624	$	23,817
Increases related to prior year tax positions	460		741		93
Decreases related to prior year tax positions	—		(246)		(522)
Increases related to current year tax positions	3,036		1,179		2,229
Settlements with taxing authorities	—		—		(166)
Lapse of statute of limitations	—		(376)		(3,827)
Balance at end of period	$	26,418	$	22,922	$	21,624